Tillement Jp
- Pharmacology top 10%
-
- Metabolism and Genetic Disorders 12
-
- Pharmaceutical studies and practices 9
- Pharmacological Effects and Toxicity Studies 7
-
- Amino Acid Enzymes and Metabolism 5
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Analytical Methods in Pharmaceuticals 5
-
- Protein Interaction Studies and Fluorescence Analysis 4
-
- Drug Transport and Resistance Mechanisms 4
- Cited by
- PharmacologyTransplantation
- Journals
- Journal of Pharmacy and Pharmacology (2 papers)Fundamental and Clinical Pharmacology (2 papers)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (2 papers)
- Partner nations
- France
In The Last Decade
Tillement Jp
68 papers receiving 352 citations
Peers
Comparison fields: 5 of 90
- Pharmacology 76
- Pharmacology 66
- Transplantation 7
- Complementary and alternative medicine 21
- Behavioral Neuroscience 9
Countries citing papers authored by Tillement Jp
This map shows the geographic impact of Tillement Jp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tillement Jp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tillement Jp more than expected).
Fields of papers citing papers by Tillement Jp
This network shows the impact of papers produced by Tillement Jp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tillement Jp. The network helps show where Tillement Jp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tillement Jp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 26 | |
| 2 | Potential interest of anti-ischemic agents for limiting cyclosporin A nephrotoxicity. | 1997 | 4 |
| 3 | 1996 | 3 | |
| 4 | Inhibition of rat cerebral mitochondrial respiration by cyclosporins A, D, and G and restoration with trimetazidine. | 1996 | 12 |
| 5 | [Pharmacology in the elderly. Changes in the pharmacodynamic response to a given drug concentration and changes in mechanisms of regulation]. | 1995 | 2 |
| 6 | Dextromethorphan O-demethylation and dextrorphan glucuronidation in a French population. | 1993 | 17 |
| 7 | Current French system of post-marketing drug surveillance. | 1990 | 4 |
| 8 | In vitro study of the binding of RU 486 and RU 42 633 to human serum proteins. | 1989 | 7 |
| 9 | Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution. | 1989 | 5 |
| 10 | 1-anilino-naphthalene 8-sulfonic acid (ANS) as a probe for the binding of antidepressant drugs to human alpha 1-acid glycoprotein (AAG). | 1989 | 4 |
| 11 | In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs. | 1986 | 22 |
| 12 | [Recurrent erythema multiforme following successive treatments with tetracyclines. Apropos of a case]. | 1984 | 4 |
| 13 | Butofilolol pharmacokinetics in chronic renal insufficiency. | 1984 | 2 |
| 14 | [Sinus bradycardia and sinoauricular block induced by carbamazepine]. | 1983 | 3 |
| 15 | [Pharmacokinetics and bioavailability of alizapride (author's transl)]. | 1982 | 1 |
| 16 | [Methods of determining principal hypolipidemic agents]. | 1979 | 2 |
| 17 | Clofibrate and enzymatic induction in man. | 1978 | 10 |
| 18 | [Pharmacological approach to the rational use of cardiotonic heterosides]. | 1977 | 5 |
| 19 | [Pharmacological approach to the mechanism of potentiation of hypnotics by various monoamine oxidase inhibitors]. | 1970 | 3 |
| 20 | [Clinical and biological aspects of some vitamin K antagonists]. | 1966 | 1 |
About Tillement Jp
Tillement Jp is a scholar working on Clinical Biochemistry, Biochemistry and Pediatrics, Perinatology and Child Health, having authored 72 papers that have together received 381 indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (12 papers), Pharmaceutical studies and practices (9 papers), Pharmacological Effects and Toxicity Studies (7 papers), Amino Acid Enzymes and Metabolism (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Analytical Methods in Pharmaceuticals (5 papers), Protein Interaction Studies and Fluorescence Analysis (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Pharmacology (76 citations), Pharmacology (66 citations) and Transplantation (7 citations). Tillement Jp has collaborated with scholars based in France. Frequent co-authors include E Albengres, Roland Zini, J. Barré, Boissier, Françoise Brée, Georges Houin, Saı̈k Urien, Didier Morin, A. Crevat and Rosa Sapena. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Fundamental and Clinical Pharmacology, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.